Dornase Alfa
- 1 December 1994
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 48 (6), 894-906
- https://doi.org/10.2165/00003495-199448060-00006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evolution of Therapy for Cystic FibrosisNew England Journal of Medicine, 1994
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosisThe Lancet, 1993
- Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic FibrosisNew England Journal of Medicine, 1992
- Cystic fibrosis: molecular biology and therapeutic implicationsScience, 1992
- The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseasesJournal of Antimicrobial Chemotherapy, 1992
- The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputumJournal of Antimicrobial Chemotherapy, 1988
- Antibiotic activity in sputumThe Journal of Pediatrics, 1986
- Pus, deoxyribonucleic acid, and sputum viscosity.Thorax, 1978
- PANCREATIC DORNASE AEROSOLS IN BRONCHOPULMONARY DISEASEAnnals of the New York Academy of Sciences, 1957